1 / 47

Nephrology Rounds

Nephrology Rounds. Riki Buchwald, ID fellow December 17 th 2008. Case. 46 y old AA man with h/o GSW to right trochanter in 8/07, s/p ORIF at OSH Admitted to Bellevue 9/07; found to have wound infection/OM with polyresistant Pseudomonas

bott
Télécharger la présentation

Nephrology Rounds

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nephrology Rounds Riki Buchwald, ID fellow December 17th 2008

  2. Case • 46 y old AA man with h/o GSW to right trochanter in 8/07, s/p ORIF at OSH • Admitted to Bellevue 9/07; found to have wound infection/OM with polyresistant Pseudomonas • Extensive debridement performed but hardware left in place • Underwent long-term treatment with polymyxin from 10/07 on. Course complicated by renal failure in 11/07 that resolved with polymyxin dose adjustment.

  3. Case • Hardware removed on 3/12/08 • Wound cx with MRSA • Received 4 week course of vancomycin and 6 week course of polymyxin after hardware removal; course completed at the end of April

  4. Case • Readmitted in 6/08 with increasing hip pain and persistent drainage • Imaging c/w erosion of the right femoral head with joint space loss, septic arthritis and chronic osteomyelitis with sinus tract to the skin surface • Debridement and washout performed on 6/18/08: OR cx grew MRSA • Treated with vancomycin • Developed worsening non oliguric renal failure with creatinine increase from 1.1 on admission to 6.8 mg/dl over 4 weeks

  5. Clinical History • PMH: - Diabetes, A1c 7.9% in 10/2007 - HTN - Anemia - Remote h/o syphilis, treated • SH: no tobacco or drug abuse • Meds: insulin, lisinopril, iron, MVI, folic acid, omeprazole, escitalopram, cyclobenzaprine, SQ heparin • ROS: several weeks of darkened urine, leg swelling; denied: dysuria, macro-hematuria, SOB, fevers, joint pain, skin rash

  6. Physical Exam • BP 150/89 HR 93 T 97.2 97% RA • Middle aged pt, appearing depressed, NAD • Sitting in wheelchair • Neck supple • Lungs: CTA • Heart: reg, nl S1 S2 • Abdomen: soft, nontender • Right thigh with surgical scar, sutures in place, mild swelling and chronic skin changes, no frank drainage • Ext: b/l 3+ LE edema

  7. Laboratory Data • Wbc 11.4, 73% PMN,18% Lymph, Eos WNL • Hgb 7.8 • Plt 332 • Hepatic: 42/64/201/0.2/8.2/3.4 • Protein electrophoresis: TP 7.7, albumin 2.4 • Globulins: alpha 1, alpha2, beta WNL, gamma 2.6 (0.5-1.3); diffuse bands

  8. Laboratory Data • 7/30: K: 5.2, Ca: 8.8, Phos: 6.0 Mg: 2.4 • 6/24: UA: protein >300 mg/dl, WBC 2-5,RBC packed, fine granular casts, RBC casts • 7/02: Urine protein: 2g/day

  9. Laboratory Data • HIV: negative • Hep B: SAb positive, SAg negative • Hep C: negative • Syphilis: IgG/TPPA positive, RPR negative

  10. Any ideas?

  11. A Diagnostic Test was Performed

  12. Normal glomerulus

  13. Nodular mesangial sclerosis

  14. Crescentic necrotizing GN

  15. RBC casts

  16. IgA C3

  17. Diagnosis • Crescentic necrotizing glomerulonephritis with focal mesangial and subepithelial deposits (IgA and C3) Differential diagnosis: - IgA Nephropathy - post infectious GN - pauci-immune ANCA-associated GN - Methicillin-resistant Staphyloccocus post infectious GN

  18. IgA nephropathy Postinfectious GN

  19. Laboratory Data • C3: 172( 75-140); C4 28.5 (10-34) • ASLO: 57 • ANA,ds DNA, ANCA: negative • Anti-GBM: negative • Urine immunofixation: negative

  20. Final Diagnosis MRSA- post infectious GN

  21. Objectives • Postinfectious Glomerulonephritis (PIGN) • Current trends in PIGN in adults • Staphylococcus and IgA dominant PIGN

  22. Postinfectious Glomerulonephritis • Acute postinfectious GN (APIGN) = disease of childhood • Commonly following a streptococcal infection (= APSGN) • Clinical presentation: 3 phase sequence: infection - interval - nephritic syndrome • Course of disease: 1 week: onset of diuresis 4 weeks: normalization of creatinine 3-6 months: resolution of hematuria; resolution of mesangial hypercellularity Years: resolution of proteinuria

  23. APIGN: Histology Humps

  24. APIGN: Outcome • Long term follow up studies: excellent prognosis for most children with the epidemic form • A Japanese study followed 138 children with non-epidemic form: None developed renal insufficiency, all had normal serum complement within 12 weeks, resolution of proteinuria within 3 yrs and hematuria within 4 yrs (Kasahara T et al, Pediatr Int 2001; 43: 364) • A 12-17 yrs f/u study of 534 children and adults in Trinidad showed complete recovery in 96.5% (Potter EV et al, NEJM 1982; 307: 725) • A 2005 study from Brazil studied 56 patients for 5.4 yrs who had APIGN related to an outbreak of Streptococcus zooepidemicus: 30% with HTN, 49 % with reduced GFR, 22% with microalbuminuria (Sesso R et al, Nephrol Dial Transplant 2005; 20:1808) • Literature reports recovery rate in adults 53-76%

  25. APIGN: What is New in Adults? Retrospective studies: • Keller CK et al, Q J Med 1994; 87: 97 - Germany 1984-1993; 30 patients • Montseny JJ et al, Medicine 1995; 74: 63 - France 1976 - 1993; 76 patients • Moroni G et al, Nephrol Dial Transplant 2002; 17: 1204 - Italy 1979-1999; 50 patients • Nasr SH et al, Medicine 2008; 87: 21 - Columbia University 1995-2005; 92 patients

  26. No comorbidities + comorbidities APIGN in Adults • % of all renal biopsies: 0.6% - 4.6% • Median age 49 - 58 yrs • Underlying disease: 40-50% - Alcoholism +/- cirrhosis 2 - 57% - Diabetes 8 - 29% - COPD 7 - 33% - IVDU 3 - 27% - Malignancy 5 - 10% Moroni G et al 2002

  27. Endocapillary proliferation: 70-100% Crescents (> 20-30%) : 14 - 36% Interstitial infiltration: 30 - 80% ATN: 20 - 40% IF: C3 deposits: 93 - 100% C1: 18 - 35% IgG deposits: 55 - 65% IgM/IgA: 30 - 45% EM: Mesangial deposits: 33 - 90% Subendothelial: 44 - 75% Humps: 94 - 100% APIGN: Presentation • Nephritic syndrome: 60% • Nephrotic Syndrome: 30-50% • Mean serum creatinine: 1.5-6.4 mg/dl (with comorbidities/crescentic GN) • Mean 24 hr-protein: 3.6 g (with comorbidities)

  28. Streptococcus: 14-47% Staphylococcus: 12-24% Gram negatives: 1-22% 24-59% w/o microbiologic diagnosis Nasr et al: Mean latent period: 3 weeks 2 weeks (endocarditis), 3 weeks (SSTI), 4 weeks (URI) 8% of patients simultaneous diagnosis (20% of pt with endocarditis and 27% with PNA) URI: 24-44% SSTI: 5-25% Lung: 16-18% Endocarditis: 1-13% Dental: 0-13% UTI: 1-12% Sites of Infection and Microbiology

  29. Comorbidities and Histology With comorbidities No comorbidities Moroni G et al, Nephrol Dial Transplant 2002; 17: 1204

  30. Outcome • CR 28-64% PRD 27-53% ESRD 4-17% Death 4-11% • Correlates of outcome: • - CR: younger age, no underlying disease • h/o URI • endocapillary disease, • no crescents or subendothelial deposits • no interstitial inflammation • - PRD: alcoholism • nephrotic syndrome • crescentic GN, interstitial fibrosis • - ESRD:higher baseline creatinine • underlying diabetic GS NasrSH et al, Medicine 2008; 87: 21

  31. % PIGN of all biopsies % with “atypical” infection sites % complete remission % with severe interstitial infiltration Moroni G et al, Nephrol Dial Transplant 2002; 17: 1204

  32. Do Steroids Matter ? • Montseny et al: 17 pt (12 with crescentic GN) treated with steroids, 8 additionally with cyclophosphamide: 2 died, 2 on HD, 3 with progressive CD, 5 with stable proteinuria, 5 with CR • Moroni et al: CR or partial remission in 54% treated with steroids vs 72% of untreated (but pt with steroids with higher creatinine and interstitial inflammation) • Nasr et al: 33% of 52 pt treated with steroids Indications: renal insufficiency with/without crescents CR in 12/17 patients with steroid therapy and 10/23 without (p=0.116) NasrSH et al, Medicine 2008; 87: 21 Moroni G et al, Nephrol Dial Transplant 2002; 17: 1204 Montseny JJ et al, Medicine 1995; 74: 63

  33. Staph and the Kidney • 2 staphylococcal associated GN: - acute proliferative exudative GN associated with S. aureus endocarditis (resembling poststreptococcal GN) - membranoproliferative GN associated with S. epidermidis and ventricular shunt infections (“shunt nephritis”) Nasr SH et al, Hum Pathol 2003, 34: 1235

  34. MRSA and PIGN • In 1980, Spector et alfirst reported 3 pt with S. aureus visceral abscesses who developed acute mesangial proliferative GN with mesangial IgA deposits • In 1995, Koyama et al reported 10 pt who developed a rapidly progressive GN with nephrotic syndrome associated with MRSA infections (abdominal 8, PNA 2, arthritis 1, phlegmon 1) • Renal biopsy in 6 pt showed proliferative GN with various degrees of crescent formation and glomerular deposition of IgA , IgG and C3 • Elevated serum IgA/IgG and immune complexes levels • High number of T cells with Vb+ usage in the TCR: ? Superantigen driven event • Named “MRSA Nephritis” or “Superantigen- related Nephritis” Spector DA et al, Clin Nephrol 1980; 14: 256 Koyama A et al, Kidney Internat 1995; 47: 207

  35. MRSA and PIGN • Recent reports: similar features after MSSA and MRSE infections • Clinical presentation: - acute RF with hematuria, severe proteinuria - onset 2-16 weeks after infection - +/- purpura, +/- hypocomplementemia • Mostly mesangial proliferative GN, often with crescents and (pre-) dominant mesangial IgA deposits • Several cases do not have subepithelial humps, the “hallmark” of PIGN • Treatment of infection lead to resolution of GN; however 40-60% of pt developed ESRD • Steroid treatment was related to the death in 2 people but recent report suggest positive outcome if used after cure of infection Nagaba Y et al, Nephron 2002; 92: 297 Yoh K et al, Nephrol Dial Transplant 2000; 15: 1170 Shimizu Y et al, J Nephrol 2005; 18: 249 Okuyama S, Clin Nephrol 2008; 70: 344

  36. Pathogenesis • Link between staphylococcal enterotoxins and T cell/cytokine activation? • Superantigen triggered cytokine activation leads to class switching to IgA? • Link to a staphylococcal cell wall antigen that co-localizes in glomeruli of patients with MRSA nephritis? • Other IgA dominant immune responses against staphylococcal antigens? (eg an envelope antigen called ‘probable adhesin’ that is also found in IgA nephropathy) Nagaba Y et al, Nephron 2002; 92: 297 Yoh K et al, Nephrol Dial Transplant 2000; 15: 1170 Shimizu Y et al, J Nephrol 2005; 18: 249

  37. Diabetes, Staph and the Kidney • In 2003, Nasr et al in New York reported 5 pt with DM who developed an IgA dominant GN after staphylococcal infection • Histology showed diabetic nephropathy with superimposed endocapillary proliferation with neutrophils and some degree of interstitial inflammation • IgA sole immunoglobulin in 3 cases; IF with mesangial or mesangial/capillary granular IgA and C3 staining • EM: all cases with predominantly mesangial deposits and sparse subepithelial deposits • Findings were similar to IgA nephropathy but all pt had low complement, endocapillary hypercellularity and humps Nasr et al, Hum Pathol 2003; 34: 1235

  38. Endocapillary proliferation Nodular sclerosis Subendothelial and subepithelial deposits Granular IgA

  39. IGA-PIGN vs IgA nephropathy IgA nephropathy: , IgA1 and J chain predominance? Nasr SH et al, Kidney International 2007; 71: 1317

  40. Diabetes and IgA nephropathy • Increased serum levels of IgA and IgA immune complexes - secondary to (silent) mucosal infection - abnormal IgA clearance (abnormal glycosylation or sialylation) • Thickened BM and mesangial sclerosis hinders subepithelial deposit formation >> predominantly mesangial deposition Nasr SH et al, Kidney International 2007; 71: 1317

  41. IgA predominant postinfectious GN • Recently, Haas et al added 13 cases from John Hopkins University • Selection criteria included IgA deposits + 3 or more subepithelial humps, no clinical history • Not only associated with staphylococcal infection Haas M et al, Hum Pathol 2008; 39: 1309

  42. Case follow-up • 7/11: Proximal femoral osteotomy and acetabular excavation performed; antibiotic cement beads with vancomycin/tobramycin placed • On 7/17, vancomycin switched to linezolid given worsening renal failure • Creatinine slowly improved: 7/30 8.9 8/14 5.9 10/08 2.7

  43. Summary • Epidemiology of APIGN is shifting • Diabetes, alcoholism and age emerge as major risk factor; prognosis is worse in pt with comorbidities and renal inflammation • Microbiology is changing and staphylococci are increasingly important in APIGN • Histologic pattern are changing, especially in immunocompromised persons

  44. Summary • IgA predominant APIGN is recognized as 3rd entity of staphylococcal associated GN • IgA dominant PIGN can be associated with diabetic nephropathy • Exact pathologic diagnosis and pathogenesis is still under debate • This entity has to be differentiated from IgA nephropathy (and pauci-immune ANCA related GN) • Treatment of infection can lead to recovery; however, pt with underlying diabetic GS have poor prognosis

  45. Thanks!

More Related